BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 32129701)

  • 1. The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer.
    Jin KT; Lu ZB; Lv JQ; Zhang JG
    RNA Biol; 2020 Dec; 17(12):1727-1740. PubMed ID: 32129701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The functional roles of exosomal long non-coding RNAs in cancer.
    Wang M; Zhou L; Yu F; Zhang Y; Li P; Wang K
    Cell Mol Life Sci; 2019 Jun; 76(11):2059-2076. PubMed ID: 30683984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of lncRNAs in the development and progression of pancreatic cancer.
    Duguang L; Jin H; Xiaowei Q; Peng X; Xiaodong W; Zhennan L; Jianjun Q; Jie Y
    Cancer Biol Ther; 2017 Dec; 18(12):927-936. PubMed ID: 29053398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential roles of exosome non‑coding RNAs in cancer chemoresistance (Review).
    Wang Y; Liu Q; Wang F
    Oncol Rep; 2021 Feb; 45(2):439-447. PubMed ID: 33416168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy-mediating microRNAs in cancer chemoresistance.
    Jing Y; Liang W; Liu J; Zhang L; Wei J; Yang J; Zhang Y; Huang Z
    Cell Biol Toxicol; 2020 Dec; 36(6):517-536. PubMed ID: 32875398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
    Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S
    Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs regulate drug resistance in cancer.
    Liu K; Gao L; Ma X; Huang JJ; Chen J; Zeng L; Ashby CR; Zou C; Chen ZS
    Mol Cancer; 2020 Mar; 19(1):54. PubMed ID: 32164712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-Coding RNAs as Mediators of Tumor Microenvironment and Liver Cancer Cell Communication.
    Lin YH; Wu MH; Yeh CT; Lin KH
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging role of long non-coding RNAs in cancer chemoresistance: unravelling the multifaceted role and prospective therapeutic targeting.
    Singh D; Khan MA; Siddique HR
    Mol Biol Rep; 2020 Jul; 47(7):5569-5585. PubMed ID: 32601922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
    Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
    Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNAs in cancer drug resistance development.
    Majidinia M; Yousefi B
    DNA Repair (Amst); 2016 Sep; 45():25-33. PubMed ID: 27427176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of long non-coding RNAs in drug resistance of cancer.
    Zhang HD; Jiang LH; Zhong SL; Li J; Sun DW; Hou JC; Wang DD; Zhou SY; Tang JH
    Clin Genet; 2021 Jan; 99(1):84-92. PubMed ID: 32583420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNAs as biotargets in cisplatin-based drug resistance.
    Abu N; Hon KW; Jeyaraman S; Jamal R
    Future Oncol; 2018 Dec; 14(29):3085-3095. PubMed ID: 30468082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNAs Roles in Chemoresistance of Cancer Cells.
    Taghvimi S; Abbaszadeh S; Banan FB; Fard ES; Jamali Z; Najafabadi MA; Savardashtaki A; Movahedpour A
    Curr Mol Med; 2022; 22(8):691-702. PubMed ID: 34711162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway.
    Pan Y; Chen J; Tao L; Zhang K; Wang R; Chu X; Chen L
    Oncotarget; 2017 May; 8(20):33144-33158. PubMed ID: 28388536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of lncRNAs in cancer: Focusing on angiogenesis.
    Jin KT; Yao JY; Fang XL; Di H; Ma YY
    Life Sci; 2020 Jul; 252():117647. PubMed ID: 32275935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of IGF1 Signaling and IGF1-related Long Noncoding RNAs in Chemoresistance of Cancer.
    Liu L; Li X
    Curr Cancer Drug Targets; 2020; 20(5):325-334. PubMed ID: 32186268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNAs in the doxorubicin resistance of cancer cells.
    Ashrafizaveh S; Ashrafizadeh M; Zarrabi A; Husmandi K; Zabolian A; Shahinozzaman M; Aref AR; Hamblin MR; Nabavi N; Crea F; Wang Y; Ahn KS
    Cancer Lett; 2021 Jun; 508():104-114. PubMed ID: 33766750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
    Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
    Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs.
    Jiang W; Xia J; Xie S; Zou R; Pan S; Wang ZW; Assaraf YG; Zhu X
    Drug Resist Updat; 2020 May; 50():100683. PubMed ID: 32146422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.